EMEA-001729-PIP02-18

Key facts

Invented name
Oxervate
Active substance
Cenegermin
Therapeutic area
Ophthalmology
Decision number
P/0118/2019
PIP number
EMEA-001729-PIP02-18
Pharmaceutical form(s)
Eye drops solution
Condition(s) / indication(s)
Treatment of dry eye disease
Route(s) of administration
Ocular use
Contact for public enquiries
Dompé farmaceutici S.p.A.

E-mail: annabella.amatulli@dompe.com
Tel. +39 2583 83230

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating